CMC Analytical, GlaxoSmithKline, 1250 S. Collegeville Road, UP 1400, Collegeville, PA, 19426, USA.
CMC Analytical, GlaxoSmithKline, 1250 S. Collegeville Road, UP 1400, Collegeville, PA, 19426, USA.
J Pharm Biomed Anal. 2021 Sep 10;204:114251. doi: 10.1016/j.jpba.2021.114251. Epub 2021 Jul 7.
The identification and control of monoclonal antibody (mAb) critical quality attributes (CQAs) is a key component of quality by design (QbD). In this work, rapid peptide mapping and native intact charge variants analysis have been developed to comprehensively characterize and monitor mAb CQAs using a microfluidic capillary electrophoresis - mass spectrometry (CE-MS) platform. The ultrafast peptide mapping simultaneously analyzed multiple CQAs, including protein primary structure, oxidation, deamidation, succinimide, C-terminal lysine (Lys) clipping, N-terminal cyclization, and glycosylation. The microfluidic CE-MS based peptide mapping acquired results comparable to conventional but lengthy liquid chromatography - MS (LC-MS) based approach. The native intact analysis resolved mAb charge variants with a comparable resolution as commonly achieved using capillary isoelectric focusing (cIEF). Charge variants' identities were assigned based on characteristic mass shifts, knowledge learned from peptide mapping, and changes in electrophoretic mobility. Major mAb glycoforms of each charge variants were resolved and identified in the deconvoluted mass spectra. Furthermore, a model simulation was performed to reconstruct intact deconvoluted mass spectra using peptide mapping results. The reconstructed and experimentally determined intact deconvoluted mass spectra were highly correlated, suggesting that our data collected at the peptide level and intact level were consistent and highly comparable. Overall, the microfluidic CE-MS based peptide mapping and native intact charge variants analysis are high-throughput methods that have great potential to support biopharmaceutical development.
单克隆抗体 (mAb) 关键质量属性 (CQA) 的鉴定和控制是质量源于设计 (QbD) 的关键组成部分。在这项工作中,我们开发了快速肽图分析和天然完整电荷变异体分析,以使用微流控毛细管电泳 - 质谱 (CE-MS) 平台全面表征和监测 mAb CQA。超快肽图分析同时分析了多个 CQA,包括蛋白质一级结构、氧化、脱酰胺、琥珀酰亚胺、C 末端赖氨酸 (Lys) 剪接、N 末端环化和糖基化。基于微流控 CE-MS 的肽图分析结果与传统但冗长的液相色谱 - 质谱 (LC-MS) 方法相当。基于 native 的完整分析以与毛细管等电聚焦 (cIEF) 通常实现的相当分辨率解析 mAb 电荷变异体。基于特征质量位移、肽图分析中获得的知识以及电泳迁移率的变化,对电荷变异体的身份进行了赋值。在解卷积的质谱中解析并鉴定了每种电荷变异体的主要 mAb 糖型。此外,还进行了模型模拟,使用肽图结果重建完整的解卷积质谱。重建和实验确定的完整解卷积质谱高度相关,这表明我们在肽水平和完整水平上收集的数据是一致且高度可比的。总体而言,基于微流控 CE-MS 的肽图分析和天然完整电荷变异体分析是高通量方法,具有极大的潜力支持生物制药的开发。